創興資源(600193.SH):海南芙蓉興受讓漳州大洋持有的7.79%公司股份
格隆匯7月17日丨創興資源(600193.SH)公佈,公司股東漳州大洋投資股份有限公司(以下簡稱“漳州大洋”)於2024年7月16日與海南芙蓉興私募基金管理合夥企業(有限合夥)(以下簡稱“海南芙蓉興”或“受讓方”)簽訂了《股份轉讓協議》,海南芙蓉興受讓漳州大洋持有的33,139,971股公司股份,佔公司總股本的7.79%,轉讓價格為每股人民幣3.06元,轉讓價款合計為人民幣101,408,311元。
海南芙蓉興與公司控股股東、實際控制人及漳州大洋不存在關聯關係。本次權益變動不會導致公司控股股東、實際控制人發生變更。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.